← Back to headlines
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
23 Feb, 14:26 — 23 Feb, 14:26
Sources
Showing 1 of 1 sources
Related Stories
Pathologist Shares Four Simple Rules for Weight Loss
31m ago
British Actress Nikki Sanderson Reveals Abuse Over Pregnancy in Her Forties
35m ago
Son of Blind College Football Player Completes Treatment for Rare Eye Cancer
39m ago
Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory
40m ago